Evidence map›Paper›PMID 33461841›Full record

ArticleJournal of the Formosan Medical Association = Taiwan yi zhi2021

A cross-sectional seroprevalence for COVID-19 among healthcare workers in a tertially care hospital in Taiwan.

Sung-Ching Pan, Yu-Shan Huang, Szu-Min Hsieh, Yee-Chun Chen, Sui-Yuan Chang, Shan-Chwen Chang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the Formosan Medical Association = Taiwan yi zhi, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Observational
  6. Learning from the past: Taiwan's responses to COVID-19 versus SARS.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sung-Ching PanDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; The Center for Infection Control, National Taiwan University Hospital, Taipei, Taiwan.
Yu-Shan HuangDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Szu-Min HsiehDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Yee-Chun ChenDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; The Center for Infection Control, National Taiwan University Hospital, Taipei, Taiwan.
Sui-Yuan ChangDepartment of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan; Department of Medical Technology, College of Medicine, National Taiwan University, Taipei, Taiwan. Electronic address: sychang@ntu.edu.tw.
Shan-Chwen ChangDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Department of Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan. Electronic address: changsc@ntu.edu.tw.
National Taiwan University Hospital · TWNational Taiwan University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHealthcare workers (HCWs) are at the frontline during the pandemic of COVID-19 globally. According to the WHO situation report at April 17, there were 22, 073 HCWs contracted the infection. Whether the infection control policy and practice in the hospital setting can protect the HCWs is an important issue.

methodsWe performed a cross-sectional serology study in a tertiary care hospital in Taiwan to explore the sero-prevalence rate among HCWs. The participants are enrolled on a voluntary basis. A structured questionnaire was collected to gather the epidemiology character and risk factors for potential exposure. ELISA tests as Architect SARS-CoV-2 IgG (Abbott) and Elecsys Anti-SARS-CoV-2 assay (Roche) were used to detect antibody responses. If any of the tests was positive, a western blot assay was used for confirmation.

resultsThere were 194 HCWs participated during July 1 to Aug. 31, 2020. The mean age was 36.3 ± 10.4. More than half of the participants had possible hospital associated risk for COVID-19 exposure (110/192, 57.3%) and 64 had possible community risk for COVID-19 exposure (64/194, 33.0%). There was only one participant had positive test by Architect IgG test and confirmed to be negative for seasonal coronavirus and SARS-CoV-2 antibody. (Mikrogen Diagnostik, Germany).

conclusionThe cross-sectional serology study in a tertiary care hospital in Taiwan revealed no HCWs had positive serology response to SARS-CoV-2. We believe that the infection control policy and practice in the hospital and in the community are both important to prevent the disease transmission.

Indexed as

COVID-19Health PersonnelAdultCross-Sectional StudiesHospitalsHumansMiddle AgedSeroepidemiologic StudiesTaiwanCOVID-19Healthcare workersSerology

Identifiers

PMID33461841
PMCPMC7833685
OpenAlexW3119186791

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.